Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.6467
-0.0483 (-6.95%)
At close: Jun 5, 2026, 4:00 PM EDT
0.6501
+0.0034 (0.53%)
After-hours: Jun 5, 2026, 7:12 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $6.85 million as of June 5, 2026. Its market cap has decreased by -11.09% in one year.
Market Cap
6.85M
Enterprise Value
-11.20M
1-Year Change
-11.09%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $6.85M, a decrease of -39.41%. That is a compound annual growth rate of -5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 6.80M | 70.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 7.86M |
| Creative Medical Technology Holdings | 7.84M |
| PharmaCyte Biotech | 7.79M |
| Quoin Pharmaceuticals | 7.74M |
| CNS Pharmaceuticals | 7.72M |
| PMGC Holdings | 7.68M |
| Acurx Pharmaceuticals | 7.57M |
| Processa Pharmaceuticals | 7.32M |